Global Stereotactic-guided Biopsy Instrument Market By Product Type (Needle-based Biopsy Instruments, Localization Wires) And By End-Users/Application (Breast Biopsy, Lung Biopsy) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

According to Apex Market Research the Stereotactic-guided Biopsy Instrument market was valued at USD xx.xx million in 2019 and is anticipated to grow at a CAGR of xx% during the forecast period from 2020 to 2028. The report on Stereotactic-guided Biopsy Instrument market delivers detailed analysis covering major regional trends, market dynamics, and offer country-level market value of Stereotactic-guided Biopsy Instrument industry. Some of the major aspects considered during the course of research comprises definition of the product, classification of the product, industry structure, different participants in the Stereotactic-guided Biopsy Instrument ecosystem, etc. The report comprises of market value and forecast for the period from 2020 to 2028, CAGR measured for individual segment and regional market, competitive landscape of key market players, and profiling of major providers participating in the Stereotactic-guided Biopsy Instrument market.

The following manufacturers are covered in this report:
  • C. R. Bard, Inc. (U.S.)
  • Becton, Dickinson and Company (U.S.)
  • Cook Group Incorporated (U.S.)
  • Devicor Medical Products, Inc., (Leica Biosystems) (Germany)
  • Argon Medical Devices (U.S.)
  • B. Braun Melsungen AG (Germany)
  • Cardinal Health, Inc. (U.S.)
  • Olympus Corporation (Japan)
  • Boston Scientific Corporation (U.S.)
  • FUJIFILM Holdings Corporation (Japan)
  • INRAD, Inc. (U.S.)
  • Medtronic plc (Ireland)

The report estimates on the Stereotactic-guided Biopsy Instrument market economy trend, market numbers (Mn/Bn USD) and CAGR from the 2020-2028, considering 2019 as the base year. A global Stereotactic-guided Biopsy Instrument market report consist of all leading industry players, Stereotactic-guided Biopsy Instrument business sections, company profile, revenue supply by Stereotactic-guided Biopsy Instrument industry sections, global Stereotactic-guided Biopsy Instrument market trends, acquisitions and arrangements, contact info, recent development, geographic examination and even more using the assistance.

Since the onset of COVID-19 in December 2019, the governments of various countries declared lockdown and as result numerous economies around the world experienced severe economic downturn. Since early 2020, the Stereotactic-guided Biopsy Instrument market witnessed the impact of COVID-19 The report objects to provide pre-COVID-19 state of the Stereotactic-guided Biopsy Instrument market in years 2020 and 2019 and moreover it offers forecast for the Covid-19 period from 2020 to 2028.The report provides COVID-19 impact on Stereotactic-guided Biopsy Instrument market, global analysis, different challenges or threats and opportunities for stakeholders involved in the Stereotactic-guided Biopsy Instrument market.

Report Opportunity: Global Stereotactic-guided Biopsy Instrument Market

This report delivers an analytical examination of the Stereotactic-guided Biopsy Instrument market summarized in broad sections such as
  1. Stereotactic-guided Biopsy Instrument Market Summary
  2. Key Commercial Growths in the Stereotactic-guided Biopsy Instrument Industry
  3. Market Dynamics Affecting the Stereotactic-guided Biopsy Instrument Industry
  4. Important Market Trends and Future Development Scenario of the Stereotactic-guided Biopsy Instrument Market
  5. Stereotactic-guided Biopsy Instrument Market Revenue and Forecast, by Type, 2018 – 2028
  6. Competitive Landscape of Stereotactic-guided Biopsy Instrument Industry
  7. Positioning of Main Market Players in the Stereotactic-guided Biopsy Instrument Industry
  8. Stereotactic-guided Biopsy Instrument Market Revenue and Forecast, by Application, 2018 - 2028
  9. Stereotactic-guided Biopsy Instrument Market Revenue and Forecast, by End-use, 2018 - 2028
  10. Stereotactic-guided Biopsy Instrument Market Revenue and Forecast, by Geography, 2018 - 2028
Stereotactic-guided Biopsy Instrument Market Segmentation:

The report provides detailed examination of the Stereotactic-guided Biopsy Instrument market on the basis of various segments such as type, application and end-use industry. The Stereotactic-guided Biopsy Instrument market is segmented as follows:

Stereotactic-guided Biopsy Instrument Market, by Type:
  • Needle-based Biopsy Instruments
  • Localization Wires
  • Procedure Trays
  • Others
Stereotactic-guided Biopsy Instrument Market, by Application:
  • Breast Biopsy
  • Lung Biopsy
  • Colorectal Biopsy
  • Prostate Biopsy
  • Others
Geographic Coverage

The report on the Stereotactic-guided Biopsy Instrument market delivers an in depth country-level cross-sectional analysis across different regions around the globe. The report comprises of complete market value and forecast for the following countries and regions:

North America Stereotactic-guided Biopsy Instrument Market Revenue and Forecast
  • U.S.
  • Canada
Europe Stereotactic-guided Biopsy Instrument Market Revenue and Forecast
  • UK
  • Germany
  • France
  • Rest of Europe
Asia Pacific Stereotactic-guided Biopsy Instrument Market Revenue and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Stereotactic-guided Biopsy Instrument Market Revenue and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Stereotactic-guided Biopsy Instrument Market Revenue and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summary
     2.1. Global Stereotactic-guided Biopsy Instrument Market Snapshot
          2.1.1. Global Stereotactic-guided Biopsy Instrument Market By Type,2019
               2.1.1.1.Needle-based Biopsy Instruments
               2.1.1.2.Localization Wires
               2.1.1.3.Procedure Trays
               2.1.1.4.Others
          2.1.2. Global Stereotactic-guided Biopsy Instrument Market By Application,2019
               2.1.2.1.Breast Biopsy
               2.1.2.2.Lung Biopsy
               2.1.2.3.Colorectal Biopsy
               2.1.2.4.Prostate Biopsy
               2.1.2.5.Others
          2.1.3. Global Stereotactic-guided Biopsy Instrument Market By End-use,2019
          2.1.4. Global Stereotactic-guided Biopsy Instrument Market By Geography,2019

3. Global Stereotactic-guided Biopsy Instrument Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Stereotactic-guided Biopsy Instrument Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Stereotactic-guided Biopsy Instrument Market Size (US$), By Type, 2018 – 2028

5. Global Stereotactic-guided Biopsy Instrument Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Stereotactic-guided Biopsy Instrument Market Size (US$), By Application, 2018 – 2028

6. Global Stereotactic-guided Biopsy Instrument Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Stereotactic-guided Biopsy Instrument Market Size (US$), By End-use, 2018 – 2028

7. Global Stereotactic-guided Biopsy Instrument Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Stereotactic-guided Biopsy Instrument Market Analysis, 2018 – 2028 
          7.2.1. North America Stereotactic-guided Biopsy Instrument Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Stereotactic-guided Biopsy Instrument Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Stereotactic-guided Biopsy Instrument Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Stereotactic-guided Biopsy Instrument Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Stereotactic-guided Biopsy Instrument Market Analysis, 2018 – 2028 
          7.3.1.  Europe Stereotactic-guided Biopsy Instrument Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Stereotactic-guided Biopsy Instrument Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Stereotactic-guided Biopsy Instrument Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Stereotactic-guided Biopsy Instrument Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Stereotactic-guided Biopsy Instrument Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Stereotactic-guided Biopsy Instrument Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Stereotactic-guided Biopsy Instrument Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Stereotactic-guided Biopsy Instrument Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Stereotactic-guided Biopsy Instrument Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Stereotactic-guided Biopsy Instrument Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Stereotactic-guided Biopsy Instrument Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Stereotactic-guided Biopsy Instrument Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Stereotactic-guided Biopsy Instrument Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Stereotactic-guided Biopsy Instrument Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Stereotactic-guided Biopsy Instrument Market Analysis, 2018 – 2028 
          7.6.1.  MEA Stereotactic-guided Biopsy Instrument Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Stereotactic-guided Biopsy Instrument Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Stereotactic-guided Biopsy Instrument Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Stereotactic-guided Biopsy Instrument Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Stereotactic-guided Biopsy Instrument Providers
        8.4.1 C. R. Bard, Inc. (U.S.)
                8.1.1 Business Description
                8.1.2 C. R. Bard, Inc. (U.S.) Geographic Operations
                8.1.3 C. R. Bard, Inc. (U.S.) Financial Information
                8.1.4 C. R. Bard, Inc. (U.S.) Product Positions/Portfolio
                8.1.5 C. R. Bard, Inc. (U.S.) Key Developments
        8.4.2 Becton, Dickinson and Company (U.S.)
                8.2.1 Business Description
                8.2.2 Becton, Dickinson and Company (U.S.) Geographic Operations
                8.2.3 Becton, Dickinson and Company (U.S.) Financial Information
                8.2.4 Becton, Dickinson and Company (U.S.) Product Positions/Portfolio
                8.2.5 Becton, Dickinson and Company (U.S.) Key Developments
        8.4.3 Cook Group Incorporated (U.S.)
                8.3.1 Business Description
                8.3.2 Cook Group Incorporated (U.S.) Geographic Operations
                8.3.3 Cook Group Incorporated (U.S.) Financial Information
                8.3.4 Cook Group Incorporated (U.S.) Product Positions/Portfolio
                8.3.5 Cook Group Incorporated (U.S.) Key Developments
        8.4.4 Devicor Medical Products, Inc., (Leica Biosystems) (Germany)
                8.4.1 Business Description
                8.4.2 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Geographic Operations
                8.4.3 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Financial Information
                8.4.4 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Product Positions/Portfolio
                8.4.5 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Key Developments
        8.4.5 Argon Medical Devices (U.S.)
                8.5.1 Business Description
                8.5.2 Argon Medical Devices (U.S.) Geographic Operations
                8.5.3 Argon Medical Devices (U.S.) Financial Information
                8.5.4 Argon Medical Devices (U.S.) Product Positions/Portfolio
                8.5.5 Argon Medical Devices (U.S.) Key Developments
        8.4.6 B. Braun Melsungen AG (Germany)
                8.6.1 Business Description
                8.6.2 B. Braun Melsungen AG (Germany) Geographic Operations
                8.6.3 B. Braun Melsungen AG (Germany) Financial Information
                8.6.4 B. Braun Melsungen AG (Germany) Product Positions/Portfolio
                8.6.5 B. Braun Melsungen AG (Germany) Key Developments
        8.4.7 Cardinal Health, Inc. (U.S.)
                8.7.1 Business Description
                8.7.2 Cardinal Health, Inc. (U.S.) Geographic Operations
                8.7.3 Cardinal Health, Inc. (U.S.) Financial Information
                8.7.4 Cardinal Health, Inc. (U.S.) Product Positions/Portfolio
                8.7.5 Cardinal Health, Inc. (U.S.) Key Developments
        8.4.8 Olympus Corporation (Japan)
                8.8.1 Business Description
                8.8.2 Olympus Corporation (Japan) Geographic Operations
                8.8.3 Olympus Corporation (Japan) Financial Information
                8.8.4 Olympus Corporation (Japan) Product Positions/Portfolio
                8.8.5 Olympus Corporation (Japan) Key Developments
        8.4.9 Boston Scientific Corporation (U.S.)
                8.9.1 Business Description
                8.9.2 Boston Scientific Corporation (U.S.) Geographic Operations
                8.9.3 Boston Scientific Corporation (U.S.) Financial Information
                8.9.4 Boston Scientific Corporation (U.S.) Product Positions/Portfolio
                8.9.5 Boston Scientific Corporation (U.S.) Key Developments
        8.4.10 FUJIFILM Holdings Corporation (Japan)
                8.10.1 Business Description
                8.10.2 FUJIFILM Holdings Corporation (Japan) Geographic Operations
                8.10.3 FUJIFILM Holdings Corporation (Japan) Financial Information
                8.10.4 FUJIFILM Holdings Corporation (Japan) Product Positions/Portfolio
                8.10.5 FUJIFILM Holdings Corporation (Japan) Key Developments
        8.4.11 INRAD, Inc. (U.S.)
                8.11.1 Business Description
                8.11.2 INRAD, Inc. (U.S.) Geographic Operations
                8.11.3 INRAD, Inc. (U.S.) Financial Information
                8.11.4 INRAD, Inc. (U.S.) Product Positions/Portfolio
                8.11.5 INRAD, Inc. (U.S.) Key Developments
        8.4.12 Medtronic plc (Ireland)
                8.12.1 Business Description
                8.12.2 Medtronic plc (Ireland) Geographic Operations
                8.12.3 Medtronic plc (Ireland) Financial Information
                8.12.4 Medtronic plc (Ireland) Product Positions/Portfolio
                8.12.5 Medtronic plc (Ireland) Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Stereotactic-guided Biopsy Instrument Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Stereotactic-guided Biopsy Instrument Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Stereotactic-guided Biopsy Instrument Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Stereotactic-guided Biopsy Instrument Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Stereotactic-guided Biopsy Instrument Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Stereotactic-guided Biopsy Instrument Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Stereotactic-guided Biopsy Instrument Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Stereotactic-guided Biopsy Instrument Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Stereotactic-guided Biopsy Instrument Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Stereotactic-guided Biopsy Instrument Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Stereotactic-guided Biopsy Instrument Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Stereotactic-guided Biopsy Instrument Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Stereotactic-guided Biopsy Instrument Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Stereotactic-guided Biopsy Instrument Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Stereotactic-guided Biopsy Instrument Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Stereotactic-guided Biopsy Instrument Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Stereotactic-guided Biopsy Instrument: Market Segmentation 
FIG. 2 Global Stereotactic-guided Biopsy Instrument Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Stereotactic-guided Biopsy Instrument Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Stereotactic-guided Biopsy Instrument Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Stereotactic-guided Biopsy Instrument Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Stereotactic-guided Biopsy Instrument Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Stereotactic-guided Biopsy Instrument Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Stereotactic-guided Biopsy Instrument Providers, 2019
FIG. 11 Global Stereotactic-guided Biopsy Instrument Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Stereotactic-guided Biopsy Instrument Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Stereotactic-guided Biopsy Instrument Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Stereotactic-guided Biopsy Instrument Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Stereotactic-guided Biopsy Instrument Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Stereotactic-guided Biopsy Instrument Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Stereotactic-guided Biopsy Instrument Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Stereotactic-guided Biopsy Instrument Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Stereotactic-guided Biopsy Instrument market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 
2048

1336

OUR CLIENT